More than a dozen data-gathering programs that track deaths and disease appear to have been eliminated in the tornado of ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark ... Top-line results show that 64.7% of patients achieved clear ...